Potential and limitations of PKA/ PKG inhibitors for platelet studies

References

• Smolenski A. Novel roles of cAMP/cGMP-dependent signaling in platelets. J Thromb Haemost 2012;10(2):167–176. doi:10.1111/j.1538-7836.2011.04576.x
   PubMed Web of Science ®Google Scholar
• Makhoul S, Walter E, Pagel O, Walter U, Sickmann A, Gambaryan S, Smolenski A, Zahedi RP, Jurk K. Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets. Nitric Oxide 2018;76:71–80. doi:10.1016/j.niox.2018.03.008
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Tsikas D. A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from L-arginine or nitrite? Amino Acids 2015;47(9):1779–1793. doi:10.1007/s00726-015-1986-1
   PubMed Web of Science ®Google Scholar
• Hanff E, Bohmer A, Zinke M, Gambaryan S, Schwarz A, Supuran CT, Tsikas D. Carbonic anhydrases are producers of S-nitrosothiols from inorganic nitrite and modulators of soluble guanylyl cyclase in human platelets. Amino Acids 2016;48(7):1695–1706. doi:10.1007/s00726-016-2234-z
   PubMed Web of Science ®Google Scholar
• Tsikas D, Gambaryan S. Nitrous anhydrase activity of carbonic anhydrase II: cysteine is required for nitric oxide (NO) dependent phosphorylation of VASP in human platelets. J Enzyme Inhib Med Chem 2021;36(1):525–534. doi:10.1080/14756366.2021.1874946
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Subramanian H, Rukoyatkina N, Herterich S, Walter U. Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets. Thromb Haemost 2013;109(5):973–975. doi:10.1160/TH12-12-0916
   PubMed Web of Science ®Google Scholar
• Francis SH, Corbin JD. Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 1994;56:237–272. doi:10.1146/annurev.ph.56.030194.001321
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Geiger J, Schwarz UR, Butt E, Begonja A, Obergfell A, Walter U. Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. Blood 2004;103(7):2593–2600. doi:10.1182/blood-2003-09-3349
   PubMed Web of Science ®Google Scholar
• Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003;371(Pt 1):199–204. doi:10.1042/BJ20021535
   PubMed Web of Science ®Google Scholar
• Lochner A, Moolman JA. The many faces of H89: a review. Cardiovasc Drug Rev 2006;24(3–4):261–274. doi:10.1111/j.1527-3466.2006.00261.x
   PubMedGoogle Scholar
• Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem 2000;275(43):33536–33541. doi:10.1074/jbc.M005670200
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Butt E, Kobsar A, Geiger J, Rukoyatkina N, Parnova R, Nikolaev VO, Walter U. The oligopeptide DT-2 is a specific PKG I inhibitor only in vitro, not in living cells. Br J Pharmacol 2012;167(4):826–838. doi:10.1111/j.1476-5381.2012.02044.x
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Hauser W, Kobsar A, Glazova M, Walter U. Distribution, cellular localization, and postnatal development of VASP and Mena expression in mouse tissues. Histochem Cell Biol 2001;116(6):535–543. doi:10.1007/s00418-001-0353-3
   PubMed Web of Science ®Google Scholar
• Subramanian H, Zahedi RP, Sickmann A, Walter U, Gambaryan S. Phosphorylation of CalDAG-GEFI by protein kinase A prevents Rap1b activation. J Thromb Haemost 2013;11(8):1574–1582. doi:10.1111/jth.12271
   PubMed Web of Science ®Google Scholar
• Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 1998;273(32):20029–20035. doi:10.1074/jbc.273.32.20029
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, Lohmann SM, Walter U. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem 2010;285(24):18352–18363. doi:10.1074/jbc.M109.077602
   PubMed Web of Science ®Google Scholar
• Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012;120(15):e73–82. doi:10.1182/blood-2012-04-416594
   PubMed Web of Science ®Google Scholar
• Mergia E, Friebe A, Dangel O, Russwurm M, Koesling D. Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 2006;116(6):1731–1737. doi:10.1172/JCI27657
   PubMed Web of Science ®Google Scholar
• Eigenthaler M, Nolte C, Halbrugge M, Walter U. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem 1992;205(2):471–481. doi:10.1111/j.1432-1033.1992.tb16803.x
   PubMedGoogle Scholar
• Murray AJ. Pharmacological PKA inhibition: all may not be what it seems. Sci Signal 2008;1(22):re4. doi:10.1126/scisignal.122re4
   PubMed Web of Science ®Google Scholar
• Chen Y, Sabatini BL. The kinase specificity of protein kinase inhibitor peptide. Front Pharmacol 2021;12:632815. doi:10.3389/fphar.2021.632815
   PubMed Web of Science ®Google Scholar
• Rosado JA, Porras T, Conde M, Sage SO. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets. J Biol Chem 2001;276(19):15666–15675. doi:10.1074/jbc.M009217200
   PubMed Web of Science ®Google Scholar
• Li Z, Ajdic J, Eigenthaler M, Du X. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 2003;101(11):4423–4429. doi:10.1182/blood-2002-10-3210
   PubMed Web of Science ®Google Scholar
• Lies B, Groneberg D, Gambaryan S, Friebe A. Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase. Br J Pharmacol 2013;170(2):317–327. doi:10.1111/bph.12275
   PubMed Web of Science ®Google Scholar
• Jensen BO, Selheim F, Doskeland SO, Gear AR, Holmsen H. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide. Blood 2004;104(9):2775–2782. doi:10.1182/blood-2004-03-1058
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu J, He C, Yan R, Zhou K, Cui Q, Meng X, Li X, Zhang Y, Nie Y, et al. Protein kinase A determines platelet life span and survival by regulating apoptosis. J Clin Invest 2017;127(12):4338–4351. doi:10.1172/JCI95109
   PubMed Web of Science ®Google Scholar
• Rukoyatkina N, Butt E, Subramanian H, Nikolaev VO, Mindukshev I, Walter U, Gambaryan S, Benz PM. Protein kinase A activation by the anti-cancer drugs ABT-737 and thymoquinone is caspase-3-dependent and correlates with platelet inhibition and apoptosis. Cell Death Dis 2017;8(6):e2898. doi:10.1038/cddis.2017.290
   PubMedGoogle Scholar
• Gambaryan S, Wagner C, Smolenski A, Walter U, Poller W, Haase W, Kurtz A, Lohmann SM. Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells. Proc Natl Acad Sci U S A 1998;95(15):9003–9008. doi:10.1073/pnas.95.15.9003
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Butt E, Marcus K, Glazova M, Palmetshofer A, Guillon G, Smolenski A. cGMP-dependent protein kinase type II regulates basal level of aldosterone production by zona glomerulosa cells without increasing expression of the steroidogenic acute regulatory protein gene. J Biol Chem 2003;278(32):29640–29648. doi:10.1074/jbc.M302143200
   PubMed Web of Science ®Google Scholar
• Valtcheva N, Nestorov P, Beck A, Russwurm M, Hillenbrand M, Weinmeister P, Feil R. The commonly used cGMP-dependent protein kinase type I (cGKI) inhibitor Rp-8-Br-PET-cGMPS can activate cGKI in vitro and in intact cells. J Biol Chem 2009;284(1):556–562. doi:10.1074/jbc.M806161200
   PubMed Web of Science ®Google Scholar
• Walker-Gray R, Stengel F, Gold MG. Mechanisms for restraining cAMP-dependent protein kinase revealed by subunit quantitation and cross-linking approaches. Proc Natl Acad Sci U S A 2017;114(39):10414–10419. doi:10.1073/pnas.1701782114
   PubMed Web of Science ®Google Scholar
• Liu C, Ke P, Zhang J, Zhang X, Chen X. Protein kinase inhibitor peptide as a tool to specifically inhibit protein kinase A. Front Physiol 2020;11:574030. doi:10.3389/fphys.2020.574030
   PubMed Web of Science ®Google Scholar